SCHEMBL4151911

SCHEMBL4151911

N#CCC(=O)c1ccc(Br)cc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.46
FLT1 P17948 3/20 0.44
FLT4 P35916 3/20 0.44
KDR P35968 3/20 0.44
ALDH1A1 P00352 2/20 0.42
MAPK1 P28482 1/20 0.42
HIF1A Q16665 1/20 0.42
MAPT P10636 2/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
ERCC5 P28715 1/20 0.38
FEN1 P39748 1/20 0.38
PTPRC P08575 1/20 0.37
PTPRG P23470 1/20 0.37
HPGD P15428 1/20 0.36
NPC1 O15118 1/20 0.36
POLB P06746 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29487646 0.83 ALDH1A1 (0.62) KCNH2FLT1FLT4KDRALDH1A1
SCHEMBL954348 0.83 ALDH1A1 (0.62) KCNH2FLT1FLT4KDRALDH1A1
SCHEMBL30477042 0.80 DGAT1 (0.54) KCNH2FLT1FLT4KDRALDH1A1
SCHEMBL5306178 0.80 KCNH2 (0.52) KCNH2FLT1FLT4KDRALDH1A1
SCHEMBL31688020 0.80 CTSL (0.47) FLT1FLT4KDRALDH1A1MAPK1
SCHEMBL1855966 0.80 CTSL (0.47) FLT1FLT4KDRALDH1A1MAPK1
SCHEMBL5795125 0.80 DGAT1 (0.54) KCNH2FLT1FLT4KDRALDH1A1
SCHEMBL30356509 0.79 GSK3B (0.48) FLT1FLT4KDRALDH1A1MAPK1
SCHEMBL15756673 0.79 ALDH1A1 (0.67) FLT1FLT4KDRALDH1A1MAPK1
SCHEMBL6516476 0.79 GSK3B (0.48) FLT1FLT4KDRALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090136448-A1 Antiviral 2-Carboxy-Thiophene Compounds CORFIELD JOHN ANDREW 2009-05-28 US disclosed
US-20090136448-A1 Antiviral 2-Carboxy-Thiophene Compounds CORFIELD JOHN ANDREW 2009-05-28 US disclosed
WO-2007071434-A1 ANTIVIRAL 2-CARBOXY-THIOPHENE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2007-06-28 WO disclosed
WO-2007039146-A1 4-CARBOXY PYRAZOLE DERIVATIVES AS ANTI-VIRAL AGENTS SMITHKLINE BEECHAM CORPORATION (US) 2007-04-12 WO disclosed
WO-2007039146-A1 4-CARBOXY PYRAZOLE DERIVATIVES AS ANTI-VIRAL AGENTS SMITHKLINE BEECHAM CORPORATION (US) 2007-04-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090136448-A1 Antiviral 2-Carboxy-Thiophene Compounds EIF2AK2, HAVCR2, MAVS KCNH2 4150/4885FLT1 1613/4885FLT4 1251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.